Licensing of antirheumatic drugs: are the EMA and FDA on the same page?
Joint Bone Spine
.
2013 Mar;80(2):121-3.
doi: 10.1016/j.jbspin.2012.09.024.
Epub 2012 Nov 7.
Authors
Bernard Bannwarth
,
Driss Berdaï
,
Marie Kostine
PMID:
23141714
DOI:
10.1016/j.jbspin.2012.09.024
No abstract available
Publication types
Editorial
MeSH terms
Antirheumatic Agents / therapeutic use*
Europe
Humans
Licensure*
Rheumatic Diseases / drug therapy*
United States
United States Food and Drug Administration*
Substances
Antirheumatic Agents